DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tekturna HCT (Aliskiren / Hydrochlorothiazide) - Coronary Artery Disease - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Coronary Artery Disease (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tekturna HCT (Aliskiren / Hydrochlorothiazide) where reactions include coronary artery disease. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Tekturna HCT side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: male

Reactions: Asthma, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease

Drug(s) suspected as cause:
Tekturna HCT



Possible Tekturna HCT side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: male

Reactions: Coronary Artery Disease, Myocardial Infarction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tekturna HCT
    Dosage: 1 df (300/25mg), qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-08-10

Tekturna
    Dosage: 150 mg, unk
    Indication: Hypertension
    Start date: 2007-07-13

Other drugs received by patient: Carvedilol; Amlodipine Besilate W / Olmesartan Medoxomil; Diltiazem HCL



Possible Tekturna HCT side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-12

Patient: male

Reactions: Asthma, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease

Drug(s) suspected as cause:
Tekturna HCT

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017